Deferiprone is associated with worsening Parkinson’s symptoms in patients naïve to dopaminergic drugs
1. Deferiprone was associated with an increase in MDS-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) scores compared to placebo, indicating worsening ...
